Optometry & Visual Performance 172 Volume 14 | Issue 2 | June 2026 While more research is needed, it is plausible that an optimistic disposition could be a protective factor against the psychosomatic components of eye diseases. Healing the Mind to Heal the Eye: A New Therapeutic Frontier The profound connection between mind and vision opens up a new and vital therapeutic frontier. If psychological distress can cause and exacerbate eye disease, then psychological interventions should be a core component of comprehensive eye care. This moves beyond simply acknowledging the emotional burden of vision loss and toward actively using psychological tools to protect and improve visual health. Mindfulness-based stress reduction (MBSR), a structured program that teaches patients to cultivate present-moment awareness, has shown remarkable promise. In a randomized controlled trial involving patients with glaucoma, an eight-week MBSR program resulted in significant reductions in intraocular pressure and lower levels of stress biomarkers, such as cortisol and pro-inflammatory cytokines, compared to a control group.17 These findings provide powerful evidence that training the mind can induce measurable physiological changes in the eye. Cognitive behavioral therapy (CBT) is another powerful tool. CBT helps individuals identify and reframe the negative thought patterns and behaviors that contribute to stress and anxiety. For a patient struggling with the diagnosis of a progressive eye disease, CBT can help them manage their fears, improve coping strategies, and reduce the very stress that might be accelerating their condition.18 Biofeedback techniques, which allow patients to gain conscious control over physiological processes like muscle tension and heart rate, can also be employed to help patients manage the physical manifestations of anxiety that impact vision.5 The future of both optometry and ophthalmology lies in embracing this integrated mind-body model. It calls for greater collaboration between eye care professionals and mental health specialists, mainly with psychologists and therapists. It means that screening for depression and anxiety in all optometry and ophthalmology clinics should become as routine as measuring intraocular pressure. It suggests that prescribing stress-management techniques alongside eye drops is not alternative medicine, but evidence-based, personalized care, and can lead to very satisfied patients.19 The journey of a photon from an object to the back of our retina is only the first step in the complex miracle of sight. The final image we perceive is a collaborative masterpiece, co-authored by our eyes and our minds. By understanding and respecting the profound influence of our psychology—from the neurochemical storms of stress to the subtle biases of our personality—we can move beyond a purely mechanistic view of vision. We can begin treating the whole person, fostering not only healthier eyes but also a calmer, more resilient mind capable of seeing the world in its fullest, most vibrant light. There is a strong need for an interdisciplinary approach to the treatment of these patients, and eye care professionals should play a leading role. References 1. Sabel BA, Sabel J. Mental stress as consequence and cause of vision loss: The dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA J 2018;9(2):11933. 2. Harrington DC. Psychosomatic manifestations: Ophthalmology. Trans Am Acad Ophthalmol Otolaryngol 1947;52:78-89. 3. Herman JP, McKlveen JM, Ghosal S, Kopp B, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comp Physiol 2016;6(2)603-21. 4. Siesky B, Harris A. The relationship between stress and glaucoma. J Glaucoma 2021;30(8S):S1-2. 5. Dzaka-Dizdarevic J, Sisto C. The role of the autonomic nervous system in the pathogenesis of glaucoma. Coll Antropol 2019;43(1):53-7. 6. Rovner BW, Casten RJ, Massof RW. The impact of depression on vision function in age-related macular degeneration. Invest Ophthalmol Vis Sci 2018;59(1):178-84. 7. Trent MG, Clark MS. The impact of psychological stress on diabetic retinopathy. J Diabetes Metab Disord 2020;19(2):6219. 8. Karakus S, Tunc M. The relationship between dry eye and psychological factors. Curr Eye Res 2019;44(8):819-25. 9. Spahn C, Wiek J, Burger T, Hansen L. Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 2003;87(6):704-8. 10. Ventura LM. Erratum: Psychoneuroimmunology: Application to ocular diseases. J Ocul Biol Dis Inform 2009;2(3):109-18. 11. Rowe AA, et al. Female sex hormones exacerbate retinal neurodegeneration. Sci Adv 2025;11:eadr6211. 12. Thorstenson CA, Pazda AD, Elliot AJ. Sadness impairs color perception. Psychol Sci 2020;31(6):725-33. 13. Hinojosa JA, Mercado F, Vázquez C. Positive mood enhances the perception of chromatic colors. Sci Rep 2020;10(1):1-10. 14. Carrasco M. Visual attention: The past 25 years. Vision Res 2011;51(13):1484-525. 15. Öhman A, Flykt A, Esteves F. Emotion drives attention: Detecting the snake in the grass. J Exp Psychol Gen 2001;130(3):466-78.
RkJQdWJsaXNoZXIy MjEyMDQ0Nw==